No insider purchase over the last 90 days. The latest, by Julie Tankard, was filed 15 Oct 2025.
The Biotech Growth Trust PLC: what insiders have been doing
The Biotech Growth Trust PLC is a Banks company. Its directors and officers file their transactions with RNS (LSE). Nothing new has been filed by managers of The Biotech Growth Trust PLC in twelve months, the latest record being from 15 October 2025.
Over the whole record (from 2016), the tally stands at 16 purchases and no sales.
This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- +19.7%Entry £10.65 · Close at T+90 £12.75
- +71.1%Entry £7.62 · Close at T+365 £13.04
- +60.1%Entry £7.62 · Close at T+365 £12.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended March 2026 · cache
- 369 shares@ £10.720827.5% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202510151017PR_NEWS_UKDISCLO_0105Canonical exit: 13 Jan 2026 (T+90)
- 500 shares@ £7.709312.9% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202506110920PR_NEWS_UKDISCLO_0084Canonical exit: 9 Sept 2025 (T+90)
- 10,000 shares@ £7.473661.0% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202506040919PR_NEWS_UKDISCLO_0089Canonical exit: 2 Sept 2025 (T+90)
- 1,000 shares@ £8.45728.5% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202501130707PR_NEWS_UKDISCLO_0073Canonical exit: 13 Apr 2025 (T+90)
- 1,200 shares@ £8.560515.5% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202412200528PR_NEWS_UKDISCLO_0050Canonical exit: 19 Mar 2025 (T+90)
- 1,022 shares@ £9.724572.5% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202412041137PR_NEWS_UKDISCLO_0102Canonical exit: 4 Mar 2025 (T+90)
- 3,000 shares@ £9.305541.7% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202411280741PR_NEWS_UKDISCLO_0091Canonical exit: 25 Feb 2025 (T+90)
- 5,000 shares@ £9.6939.0% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202403140810PR_NEWS_UKDISCLO_0072Canonical exit: 12 Jun 2024 (T+90)
- 3,000 shares@ £9.746842.7% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202403121239PR_NEWS_UKDISCLO_0117Canonical exit: 10 Jun 2024 (T+90)
- 1,000 shares@ £10.0133.1% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202402280519PR_NEWS_UKDISCLO_0054Canonical exit: 28 May 2024 (T+90)
- 1,000 shares@ £7.79625.5% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202308110713PR_NEWS_UKDISCLO_0071Canonical exit: 9 Nov 2023 (T+90)
- 10,000 shares@ £7.776438.1% of flowLondon Stock Exchange (XLON)ISIN GB0000385517FCA-NSM:202206140651PR_NEWS_UKDISCLO_0069Canonical exit: 12 Sept 2022 (T+90)
- 3,000 shares@ £6.9642.8% of flowLondon Stock Exchange (XLON)ISIN GB0000385517FCA-NSM:PRNRNS_201804250945PR_NEWS_UKDISCLO_0088_20200330111352005_4306Canonical exit: 17 Jul 2018 (T+90)
- 10,000 shares@ £7.15100.0% of flowLondon Stock Exchange (XLON)ISIN GB0000385517FCA-NSM:PRNRNS_201705261151PR_NEWS_UKDISCLO_0106_20200330131531476_21838Canonical exit: 24 Aug 2017 (T+90)
- 4,000 shares@ £6.65100.0% of flowLondon Stock Exchange (XLON)ISIN GB0000385517FCA-NSM:PRNRNS_201607201143PR_NEWS_UKDISCLO_0099_20200330143558513_15954Canonical exit: 18 Oct 2016 (T+90)
- 3,500 shares@ £6.65100.0% of flowLondon Stock Exchange (XLON)ISIN GB0000385517FCA-NSM:PRNRNS_201607181248PR_NEWS_UKDISCLO_0092_20200330143558409_13676Canonical exit: 16 Oct 2016 (T+90)
16 of 16 declarations
About The Biotech Growth Trust PLC
The Biotech Growth Trust PLC is an investment trust focused on the biotechnology sector. It aims to generate returns by investing in biotechnology companies globally.
